Français
English
Human health
Access to diagnosis
a global challenge
Many infectious diseases remain undiagnosed today, representing a genuine public health scourge. Even when treatments exist, the lack of reliable, accessible diagnostics means some patients miss out on appropriate care and continue to spread these diseases within their communities.
Tuberculosis, 2024: 3 million active cases out of 10.8 million went undiagnosed.
Make diagnosis accessible
At AFYIA Diagnostics, we place innovative, simple, reliable, sensitive, and affordable diagnostics at the heart of our mission. Rapid and accurate identification of infectious agents is a crucial step in improving global health, particularly in settings where access to healthcare remains limited. A rapid and accurate diagnosis is essential to:
- Identify pathogens and guide appropriate care, allowing the administration of specific antiviral or antibiotic treatments.
- Limit the transmission of pathogens through the implementation of targeted isolation and prevention measures.
- Reduce the inappropriate use of antibiotics and contribute to the fight against antibiotic resistance.
- Avoid diagnostic errors which could delay the treatment of serious pathologies, such as viral meningoencephalitis or certain bacterial infections.
- Detect epidemics early and adjust public health policies.
High-performance diagnostics
accessible to everyone
Our ambition is to make high-performance diagnostics accessible to everyone, in order to better prevent, treat, and control infectious diseases on a global scale.
